Efficacy of Communication Modalities for Promoting Flu Shots

Completed · Not applicable

Conditions studied: Influenza Vaccination, Health Promotion, Health Behavior, Risk Reduction

In brief

The purpose of this study is to test which modalities (mailed letter, short message service \[SMS\] text, or patient portal messages) are most effective for encouraging flu shots in high-risk patients.

Key facts

Study ID

NCT05509270

Run by

Geisinger Clinic

People needed

43225

Starts

2022-09-06

Expected to finish

2022-10-04

Last updated by the study team

2022-10-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Included on a list of active Geisinger patients (all patients on this list attended at least one primary care appointment at Geisinger between 10/1/2008 and 4/13/2022, and either had a Geisinger primary care provider assigned as of April 2022, or were in the Electronic Health Record [EHR] since at least September 2021 and had at least one encounter in 2020-2022)
• Aged 18 or older
• In the top 10% of risk for flu and flu complications, according to Medial's flu complications machine learning algorithm (which operates on coded EHR data)
• Has a Geisinger PCP assigned as of August 2022
• Has had an encounter in the last 2 years as of August 2022

You may not qualify if…

• Cannot be contacted via any of the communication modalities (e.g., letter, patient portal, SMS) being used in the study, either due to insufficient/missing contact information in the EHR or because they opted out of all modalities

Where it is running

• Geisinger — Danville, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.